MoneyWorks4Me

Colinz Laboratories - Quaterly Results

30 Apr 2026 Evaluate
A fair growth of 20.47% in the revenue at Rs. 17.48 millions was reported in the March 2026 quarter as compared to Rs. 14.51 millions during year-ago period.Net profit stood at Rs. 1.70  millions  compared to Rs. 1.50 millions in the corresponding previous quarter,high by 13.33%.OP of the company witnessed a marginal growth to 2.65 millions from 1.74 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 17.48 14.51 20.47 61.36 65.28 -6.00 61.36 65.28 -6.00
Other Income 1.74 0.76 128.95 4.84 2.98 62.42 4.84 2.98 62.42
PBIDT 2.65 1.74 52.30 8.91 7.94 12.22 8.91 7.94 12.22
Interest 0.11 0.16 -31.25 0.47 0.42 11.90 0.47 0.42 11.90
PBDT 2.54 1.58 60.76 8.44 7.52 12.23 8.44 7.52 12.23
Depreciation 0.39 0.35 11.43 1.56 1.31 19.08 1.56 1.31 19.08
PBT 2.15 1.23 74.80 6.88 6.21 10.79 6.88 6.21 10.79
TAX 0.45 -0.27 -266.67 1.75 1.23 42.28 1.75 1.23 42.28
Deferred Tax -0.15 -0.52 -71.15 -0.15 -0.52 -71.15 -0.15 -0.52 -71.15
PAT 1.70 1.50 13.33 5.13 4.98 3.01 5.13 4.98 3.01
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 15.16 11.99 26.42 14.52 12.16 19.39 14.52 12.16 19.39
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..